Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Uhlik

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Nature Communications|March 12, 2024
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trialDavid Hsiehchen, Muhammad S Beg, Radhika Kainthla, et al.
Nature|July 6, 2007
A transforming mutation in the pleckstrin homology domain of AKT1 in cancerJohn D Carpten, Andrew L Faber, Candice Horn, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Nature Communications|March 12, 2024
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trialDavid Hsiehchen, Muhammad S Beg, Radhika Kainthla, et al.
Nature|July 6, 2007
A transforming mutation in the pleckstrin homology domain of AKT1 in cancerJohn D Carpten, Andrew L Faber, Candice Horn, et al.
Pageof 2